Guardant Health revenue and financials

GH · NASDAQ · USD

Compare Guardant Health
$145.83Change from previous close: +0.16%Absolute change: +$0.24

Close · November 20, 2026

In the fiscal year ended December 2025, Guardant Health reported revenue of $982.02M (+32.88% year over year). The net loss was $416.28M.

Annual revenue · 2025: $982.02M
  1. $25.25M2016
  2. $49.84M2017
  3. $90.64M2018
  4. $214.38M2019
  5. $286.73M2020
  6. $373.65M2021
  7. $449.54M2022
  8. $563.95M2023
  9. $739.02M2024
  10. $982.02M2025

Fiscal year ending in December. Sources and method on the page How we analyse stocks.

At a glance

Revenue growth
+32.88%
2025 vs 2024
Net margin
-42.4%
2024: -59.0%

How Guardant Health is changing

Calculated from the annual statements; each fiscal year is labelled with the year it ends.

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Income statement · Annual
Item2025202420232022202120202019201820172016
Total revenue98273956445037428721490.649.825.2
Cost of revenue34929022715612392.570.743.231.622.1
Gross profit63344933729325119414447.418.23.1
Selling, general and administrative70554445146439929914089.766.336.1
Research and development36434836737426315086.350.725.610.9
Operating income-436-443-481-544-411-255-82.4-92.9-73.6-43.8
EBIT-436-443-481-544-411-255-82.4-92.9-73.6-43.8
EBITDA-397-400-438-508-389-239-71.0-85.8-68.4-40.2
Interest expense3.92.62.62.62.64.81.21.32.73.0
Pre-tax income-418-435-479-653-384-246-69.7-84.2-83.2-46.1
Income tax-1.31.30.71.10.30.4-1.90.00.00.0
Net income-416-436-479-655-406-254-75.7-85.1-83.2-46.1
Net income to common shareholders-416-436-479-655-406-254-75.7-85.1-89.0-46.1
Basic EPS-3.32-3.56-4.28-6.41-4.00-2.60-0.84-2.80-7.07-3.53
Diluted EPS-3.32-3.56-4.28-6.41-4.00-2.60-0.84-2.80-7.07-3.53
Average shares (basic)12512311210210197.590.630.412.613.1
Average shares (diluted)12512311210210197.590.630.412.613.1

Companies in the group: same industry, similar size